Barr Prozac Appeal Claims Lilly Double Patenting; Seeks Patent Invalidation
Barr is focusing its appellate challenge of the Prozac patent ruling on double patent claims.
Barr is focusing its appellate challenge of the Prozac patent ruling on double patent claims.